Morton Capital Management »

Arrowhead Pharmaceuticals shares owned by Morton Capital Management

Quarter-by-quarter ownership of Arrowhead Pharmaceuticals (ARWR) shares owned by Morton Capital Management from 13F filings

Historical chart of Morton Capital Management investment in Arrowhead Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Arrowhead Pharmaceuticals held by Morton Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrowhead Pharmaceuticals by Morton Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $247k 3.7k 66.38

More positions owned by Morton Capital Management

Vaneck Merk Gold Etf Gold Shs (OUNZ)
Wisdomtree Tr Floatng Rat Trea (USFR)
Dimensional Etf Trust World Ex Us Core (DFAX)
Tcw Etf Trust Flexible Income (FLXR)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Vaneck Etf Trust Natural Resourc (HAP)
Microsoft Corporation (MSFT)
Apple (AAPL)
Ishares Gold Tr Ishares New (IAU)
Ishares Tr Rus 1000 Val Etf (IWD)
Dimensional Etf Trust Us Core Equity 1 (DCOR)
Dimensional Etf Trust Us Core Eqt Mkt (DFAU)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vaneck Etf Trust Gold Miners Etf (GDX)
Invesco Exchange Traded Fd T Intl Divi Achi (PID)

View all positions for Morton Capital Management

Top funds holding Arrowhead Pharmaceuticals

BlackRock
Vanguard Group
venBio Select Advisor
State Street Corporation
FMR
Geode Capital Management
Slate Path Capital
Driehaus Capital Management
Arrowstreet Capital, Limited Partnership
Deerfield Management Company
Norges Bank Investment Management
Goldman Sachs Group
Baker Bros. Advisors
Siren
Charles Schwab Investment Management

View all funds holding Arrowhead Pharmaceuticals